13 November 2015 - Deborah Wilkes
Archived
Mylan's hostile takeover bid for Perrigo has failed. The generics giant only managed to convince the owners of approximately 40% of Perrigo's shares that the time was right to sell.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.